These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells. Hung MJ; Cherng WJ; Hung MY; Wu HT; Pang JH J Hypertens; 2010 May; 28(5):940-51. PubMed ID: 20375905 [TBL] [Abstract][Full Text] [Related]
9. Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes. Paneni F; Costantino S; Castello L; Battista R; Capretti G; Chiandotto S; D'Amario D; Scavone G; Villano A; Rustighi A; Crea F; Pitocco D; Lanza G; Volpe M; Del Sal G; Lüscher TF; Cosentino F Eur Heart J; 2015 Apr; 36(13):817-28. PubMed ID: 24801072 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus. Otsuki M; Goya K; Kasayama S Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106 [TBL] [Abstract][Full Text] [Related]
11. Diabetic dyslipidaemia is associated with alterations in eNOS, caveolin-1, and endothelial dysfunction in streptozotocin treated rats. Shamsaldeen YA; Ugur R; Benham CD; Lione LA Diabetes Metab Res Rev; 2018 Jul; 34(5):e2995. PubMed ID: 29471582 [TBL] [Abstract][Full Text] [Related]
12. Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney. Komers R; Schutzer WE; Reed JF; Lindsley JN; Oyama TT; Buck DC; Mader SL; Anderson S Diabetes; 2006 Jun; 55(6):1651-9. PubMed ID: 16731827 [TBL] [Abstract][Full Text] [Related]
13. Circulating microparticles from diabetic rats impair endothelial function and regulate endothelial protein expression. Ishida K; Taguchi K; Hida M; Watanabe S; Kawano K; Matsumoto T; Hattori Y; Kobayashi T Acta Physiol (Oxf); 2016 Feb; 216(2):211-20. PubMed ID: 26235826 [TBL] [Abstract][Full Text] [Related]
14. Response to Buscemi S et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes. Zaccardi F; Pitocco D; Caputo S; Ghirlanda G Diabet Med; 2011 Jan; 28(1):126; author reply 127-8. PubMed ID: 21166858 [No Abstract] [Full Text] [Related]
16. Resveratrol Ameliorates Clonidine-Induced Endothelium-Dependent Relaxation Involving Akt and Endothelial Nitric Oxide Synthase Regulation in Type 2 Diabetic Mice. Taguchi K; Hida M; Matsumoto T; Kobayashi T Biol Pharm Bull; 2015; 38(12):1864-72. PubMed ID: 26632178 [TBL] [Abstract][Full Text] [Related]
17. Expression of VEGF, iNOS, and eNOS is increased in cochlea of diabetic rat. Liu F; Xia M; Xu A Acta Otolaryngol; 2008 Nov; 128(11):1178-86. PubMed ID: 19241604 [TBL] [Abstract][Full Text] [Related]
18. Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide. Matsui-Hirai H; Hayashi T; Yamamoto S; Ina K; Maeda M; Kotani H; Iguchi A; Ignarro LJ; Hattori Y J Pharmacol Exp Ther; 2011 Jun; 337(3):591-9. PubMed ID: 21357660 [TBL] [Abstract][Full Text] [Related]
19. Akt/eNOS pathway activation in endothelium-dependent relaxation is preserved in aortas from female, but not from male, type 2 diabetic mice. Taguchi K; Matsumoto T; Kamata K; Kobayashi T Pharmacol Res; 2012 Jan; 65(1):56-65. PubMed ID: 21933713 [TBL] [Abstract][Full Text] [Related]
20. Divergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasis. Godo S; Shimokawa H Free Radic Biol Med; 2017 Aug; 109():4-10. PubMed ID: 27988339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]